Where does AltaThera Pharmaceuticals LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), AltaThera Pharmaceuticals LLC ranks #34,198 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does AltaThera Pharmaceuticals LLC hold?

AltaThera Pharmaceuticals LLC holds 7 US utility patents granted between 2019 and 2025, spanning 4 technology areas.

What is AltaThera Pharmaceuticals LLC's Innovation Score?

AltaThera Pharmaceuticals LLC has an Innovation Score of 42.5 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does AltaThera Pharmaceuticals LLC focus on?

AltaThera Pharmaceuticals LLC's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 7 patents, ranking #3,032 of 7,163 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is AltaThera Pharmaceuticals LLC's patent grant rate increasing or decreasing?

AltaThera Pharmaceuticals LLC's recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for AltaThera Pharmaceuticals LLC's patents?

AltaThera Pharmaceuticals LLC's patents average 13.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the AltaThera Pharmaceuticals LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

AltaThera Pharmaceuticals LLC

USPTO PatentsView assignee record - 7 granted patents across 4 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Altathera ranks #34,198 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 4 technology areas.

#34,198
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.5/100): 13.7
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R34198 · US Corporation #34,198 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #34,198/49,997
PHOTO-FINISH Alpha Motor
CPC-NARROW A61K · 4 areas
INNOV-PAR 42.5/100
CLAIMS-RICH 13.7 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Alpha Motor Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Altathera’s 42.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (17%) Velocity 20.0 pts (47%) Breadth 7.1 pts (17%) Claim depth 8.2 pts (19%)

Qualcomm Incorporated · highest

85
AltaThera Pharmaceut… · this assignee

42
3D Lighting… · lowest

7

What this shows Altathera's Innovation Score is 42.5/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Altathera?

Each dot is one of Altathera’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Altathera’s own 13.7 claims/patent is ABOVE the 11.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Altathera vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Altathera's grants concentrate

AltaThera Pharmaceuticals LLC is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2019. By volume, Altathera sits between Alpha Motor Corporation and Altra, Inc..

Altathera's three-year grant acceleration

AltaThera Pharmaceuticals LLC shows 3 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Alpha Motor

7
Alpha Power Solut…

7
Alpha Scientific

7
Alphaics

7
Altaeros Energies

7
Altevac

7
Altitude Medical

7
Altra

7
Altathera Pharmac… ◀

7

What this shows AltaThera holds 7 patents at rank #34,302, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near AltaThera

By rank, the assignees closest to #34,302 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in AltaThera's primary technology class.

Altathera's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

AltaThera Pharmaceuticals LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	14.3%
2022	1	14.3%
2023	2	28.6%
2025partial year	3	42.9%

Which technologies does AltaThera Pharmaceuticals LLC patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

AltaThera Pharmaceuticals LLC's patent record in context - here's where to go next.

AltaThera Pharmaceuticals LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #34,198 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare AltaThera Pharmaceuticals LLC against Alpha Motor Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.